Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Related GILD
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)
Related CELG
#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict
Fast Money Traders Share The Stocks To Buy In An Uptrend Market
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters